Top Story

TURQUOISE-II: Demographics, viral factors did not predict SVR after 3D regimen

November 21, 2014

BOSTON — Sustained virologic response rates after treatment with an all-oral regimen of coformulated ABT-450 boosted with ritonavir, ombitasvir and dasabuvir plus ribavirin were high in patients with hepatitis C virus genotype 1 infection and cirrhosis across a broad range of subgroups and regardless of baseline characteristics.

Michael W. Fried, MD, professor of medicine and director of the University of North Carolina Liver Center, presented new data from the TURQUOISE-II study at The Liver Meeting.

EMA panel recommends approval of DAA regimen for patients with HCV

November 21, 2014
The European Committee for Medicinal Products for Human Use, or CHMP, granted a positive opinion for the recommendation of Viekirax plus Exviera, with or without…

Commission approves ledipasvir/sofosbuvir combo for marketing in EU

November 20, 2014
The European Commission granted marketing authorization to Gilead Sciences for its once-daily single tablet regimen of Harvoni for the treatment of adults with chronic…
Check Hep C program effective in identifying HCV in New York Meeting News CoveragePerspective

Check Hep C program effective in identifying HCV in New York

November 20, 2014
BOSTON — The Check Hep C program, a community-based initiative in New York that focuses on finding and testing individuals with hepatitis C virus infection in…
More News Headlines »
CME
HCV Consults: Volume 1, Number 3

HCV Consults: Volume 1, Number 3

This activity is supported by educational grants from AbbVie and Genentech, Inc.

More »
Meeting News Coverage Video
thumbnail for video 3895262652001

Early liver transplantation could improve survival rates for patients with alcoholic hepatitis

November 17, 2014
BOSTON — Ibrahim A. Hanouneh, MD, hepatologist at Cleveland Clinic, discussed results of a study that compared…
More »
CME
j64a_activity

CRITICAL ISSUES IN HBV: Considerations in Optimizing HBV Treatment

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

Hepatitis B virus (HBV) infection is a global epidemic with a worldwide burden. Physicians must address the importance…
More »
morganatic-roan